---
title: "RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma"
date: "2025-09-02T04:00:00.000Z"
publishedDate: "2 septembre 2025"
summary: "Conditions : Recurrent Meningioma Interventions : Drug: Actinium Ac 225 DOTATATE RYZ101; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Echocardiography Test; Radiation: Gallium Ga 68-DOTATATE; Drug: L-lysine/L-arginine-containing Amino Acid; Procedure: Magnetic Resonance Imaging; Procedure: Multigated Acquisition Scan; Procedure: Positron Emission Tomography; Procedure: Somatostatin Receptor Positron Emission Tomography Sponsors : Joshua Palmer; RayzeBio, Inc. Not yet recruiting"
importance: ""
sourceUrl: "https://clinicaltrials.gov/study/NCT07150806?term=interventional+radiology&aggFilters=status%3A"
tags: ["France", "Actualité", "ClinicalTrials.gov — ta recherche"]
permalink: "/papers/2025-09-02-ryz101-for-the-treatment-of-progressive-or-recurrent-intracranial-meningioma"
imageUrl: ""
imageCredit: ""
---

## L’essentiel

Conditions : Recurrent Meningioma Interventions : Drug: Actinium Ac 225 DOTATATE RYZ101; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Echocardiography Test; Radiation: Gallium Ga 68-DOTATATE; Drug: L-lysine/L-arginine-containing Amino Acid; Procedure: Magnetic Resonance Imaging; Procedure: Multigated Acquisition Scan; Procedure: Positron Emission Tomography; Procedure: Somatostatin Receptor Positron Emission Tomography Sponsors : Joshua Palmer; RayzeBio, Inc. Not yet recruiting

## Lien source

https://clinicaltrials.gov/study/NCT07150806?term=interventional+radiology&aggFilters=status%3A
